Fondaparinux for Management of Heparin-induced Thrombocytopenia after Cardiovascular Intervention: A Systematic Review

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 13, Iss. 2, 2015-08 ,pp. : 82-86

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

By Job Harenberg   Ingrid Jörg   Tivadar Fenyvesi   Lukas Piazolo  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 1, 2005-02 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

By Job Harenberg   Ingrid Jörg   Tivadar Fenyvesi   Lukas Piazolo  

Journal of Thrombosis and Thrombolysis, Vol. 20, Iss. 2, 2005-10 ,pp. : 137-137

Springer Publishing Company

Access to resources Recommend Favorite

Heparin-induced thrombocytopenia: present and future

By Cuker Adam  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 3, 2011-04 ,pp. : 353-366

Springer Publishing Company

Access to resources Recommend Favorite

Argatroban caused severe hypercholesterolaemia in a chronic haemodialysis patient with heparin-induced thrombocytopenia: an unreported adverse effect

By Nakagawa Tetsuya  

NDT PLUS, Vol. 1, Iss. 4, 2008-08 ,pp. : 277-277

Oxford University Press

Access to resources Recommend Favorite